These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2944482)

  • 1. Human factor XIa cleaves fibrinogen: effects on structure and function.
    Scott CF; Mentzer RL; Budzynski AZ; Colman RW
    Arch Biochem Biophys; 1986 Sep; 249(2):480-8. PubMed ID: 2944482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of factor XI in plasma is dependent on factor XII.
    Brunnée T; La Porta C; Reddigari SR; Salerno VM; Kaplan AP; Silverberg M
    Blood; 1993 Feb; 81(3):580-6. PubMed ID: 8427954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces.
    Naito K; Fujikawa K
    J Biol Chem; 1991 Apr; 266(12):7353-8. PubMed ID: 2019570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function.
    Scott CF; Silver LD; Purdon AD; Colman RW
    J Biol Chem; 1985 Sep; 260(19):10856-63. PubMed ID: 3875612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate.
    Scott CF; Colman RW
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11189-93. PubMed ID: 1454798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.
    Baglia FA; Walsh PN
    J Biol Chem; 2000 Jul; 275(27):20514-9. PubMed ID: 10781579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface independent factor XI activation by thrombin in the presence of high molecular weight kininogen.
    von dem Borne PA; Koppelman SJ; Bouma BN; Meijers JC
    Thromb Haemost; 1994 Sep; 72(3):397-402. PubMed ID: 7855791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.
    Scott CF; Schapira M; James HL; Cohen AB; Colman RW
    J Clin Invest; 1982 Apr; 69(4):844-52. PubMed ID: 7076850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.
    Berrettini M; Schleef RR; Heeb MJ; Hopmeier P; Griffin JH
    J Biol Chem; 1992 Oct; 267(28):19833-9. PubMed ID: 1400299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen.
    Kang EP; Triantaphyllopoulos DC
    Biochim Biophys Acta; 1977 Feb; 490(2):430-42. PubMed ID: 138448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of charged groups in factor XI/XIa activity.
    Morgan K; Schiffman S
    J Biol Chem; 1982 Oct; 257(19):11284-7. PubMed ID: 6981645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.
    Baglia FA; Sinha D; Walsh PN
    Blood; 1989 Jul; 74(1):244-51. PubMed ID: 2665835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Houston: a dysfibrinogen exhibiting defective fibrin monomer aggregation and alpha-chain cross-linkages.
    Weinger RS; Rudy C; Moake JL; Conlon CL; Cimo PL
    Am J Hematol; 1980; 9(3):237-48. PubMed ID: 6165239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.
    Sinha D; Seaman FS; Koshy A; Knight LC; Walsh PN
    J Clin Invest; 1984 Jun; 73(6):1550-6. PubMed ID: 6609936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
    Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
    Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domain V of beta2-glycoprotein I binds factor XI/XIa and is cleaved at Lys317-Thr318.
    Shi T; Giannakopoulos B; Iverson GM; Cockerill KA; Linnik MD; Krilis SA
    J Biol Chem; 2005 Jan; 280(2):907-12. PubMed ID: 15522884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.